TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Miltenyi Biotec Norden AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
101,319
|
86,616
|
76,177 |
Financial expenses |
1
|
13
|
1 |
Earnings before taxes |
7,335
|
8,180
|
6,277 |
EBITDA |
8,818
|
9,043
|
6,868 |
Total assets |
42,042
|
35,537
|
39,151 |
Current assets |
36,629
|
30,377
|
37,275 |
Current liabilities |
28,901
|
28,164
|
23,558 |
Equity capital |
13,141
|
7,373
|
15,593 |
- share capital |
34
|
33
|
36 |
Employees (average) |
22
|
19
|
18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
31.3%
|
20.7%
|
39.8% |
Turnover per employee |
4,605
|
4,559
|
4,232 |
Profit as a percentage of turnover |
7.2%
|
9.4%
|
8.2% |
Return on assets (ROA) |
17.4%
|
23.1%
|
16.0% |
Current ratio |
126.7%
|
107.9%
|
158.2% |
Return on equity (ROE) |
55.8%
|
110.9%
|
40.3% |
Change turnover |
14,258
|
16,609
|
7,428 |
Change turnover % |
16%
|
24%
|
11% |
Chg. No. of employees |
3
|
1
|
3 |
Chg. No. of employees % |
16%
|
6%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.